171 related articles for article (PubMed ID: 25031446)
1. The Bristol stool scale and its relationship to Clostridium difficile infection.
Caroff DA; Edelstein PH; Hamilton K; Pegues DA;
J Clin Microbiol; 2014 Sep; 52(9):3437-9. PubMed ID: 25031446
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the Bristol Stool Form Chart scoring system for the laboratory processing of faecal samples in suspected Clostridioides difficile cases.
Corrigan RA; Sithamparanathan K; Kenny C; Wong THN
J Hosp Infect; 2020 May; 105(1):95-97. PubMed ID: 31836551
[TBL] [Abstract][Full Text] [Related]
3. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
[TBL] [Abstract][Full Text] [Related]
4. Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.
Janezic S; Strumbelj I; Rupnik M
J Clin Microbiol; 2011 Aug; 49(8):3024-5. PubMed ID: 21632902
[TBL] [Abstract][Full Text] [Related]
5. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.
Dubberke ER; Han Z; Bobo L; Hink T; Lawrence B; Copper S; Hoppe-Bauer J; Burnham CA; Dunne WM
J Clin Microbiol; 2011 Aug; 49(8):2887-93. PubMed ID: 21697328
[TBL] [Abstract][Full Text] [Related]
6. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.
Luna RA; Boyanton BL; Mehta S; Courtney EM; Webb CR; Revell PA; Versalovic J
J Clin Microbiol; 2011 Mar; 49(3):851-7. PubMed ID: 21209161
[TBL] [Abstract][Full Text] [Related]
7. Detection of C. difficile toxin as a model assay for performing fully automated high-throughput RT-PCR on clinical stool samples.
Eigner U; Nörz D; Reucher S; Furrer J; Sun J; Chu K; Kolb M; Hefner N; Pfefferle S; Lütgehetmann M
J Microbiol Methods; 2020 May; 172():105882. PubMed ID: 32119956
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic performance and accuracy of 3 molecular assays for the detection of Clostridium difficile in stool samples, compared with the Xpert® C. difficile assay.
Azrad M; Tkhawkho L; Hamo Z; Peretz A
J Microbiol Methods; 2020 Jan; 168():105784. PubMed ID: 31758952
[TBL] [Abstract][Full Text] [Related]
9. Need for clinicopathologic correlation of Clostridium difficile colitis in view of molecular diagnosis.
Guarner J; Kraft CS
Clin Infect Dis; 2012 Jan; 54(1):156. PubMed ID: 22187416
[No Abstract] [Full Text] [Related]
10. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
Boone JH; Archbald-Pannone LR; Wickham KN; Carman RJ; Guerrant RL; Franck CT; Lyerly DM
Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1045-51. PubMed ID: 24449345
[TBL] [Abstract][Full Text] [Related]
11. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.
Darkoh C; Dupont HL; Kaplan HB
J Clin Microbiol; 2011 Dec; 49(12):4219-24. PubMed ID: 21976761
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
[TBL] [Abstract][Full Text] [Related]
13. High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.
Dominguez SR; Dolan SA; West K; Dantes RB; Epson E; Friedman D; Littlehorn CA; Arms LE; Walton K; Servetar E; Frank DN; Kotter CV; Dowell E; Gould CV; Hilden JM; Todd JK
Clin Infect Dis; 2014 Aug; 59(3):401-3. PubMed ID: 24785235
[TBL] [Abstract][Full Text] [Related]
14. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea.
Nistico JA; Hage JE; Schoch PE; Cunha BA
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
Deak E; Miller SA; Humphries RM
J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the chromogenic agar chromID C. difficile.
Eckert C; Burghoffer B; Lalande V; Barbut F
J Clin Microbiol; 2013 Mar; 51(3):1002-4. PubMed ID: 23269743
[TBL] [Abstract][Full Text] [Related]
17. Two-year analysis of Clostridium difficile ribotypes associated with increased severity.
Herbert R; Hatcher J; Jauneikaite E; Gharbi M; d'Arc S; Obaray N; Rickards T; Rebec M; Blandy O; Hope R; Thomas A; Bamford K; Jepson A; Sriskandan S
J Hosp Infect; 2019 Dec; 103(4):388-394. PubMed ID: 31220480
[TBL] [Abstract][Full Text] [Related]
18. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.
Hink T; Burnham CA; Dubberke ER
Anaerobe; 2013 Feb; 19():39-43. PubMed ID: 23247066
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.
Lalande V; Barrault L; Wadel S; Eckert C; Petit JC; Barbut F
J Clin Microbiol; 2011 Jul; 49(7):2714-6. PubMed ID: 21525213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
